Physician profile
Ryan S Jawitz
NPI 1659513729
$3,820.35
in general payments reported to CMS, 2019-2025
28 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $187 · 2021: $419 · 2022: $594 · 2023: $984 · 2024: $834 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,187.99 |
| Education | $107.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $991.55 | 2019-2025 | |
| Janssen Biotech, INC. | $426.00 | 2020-2025 | Tremfya, Simponi, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $307.22 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $301.09 | 2022-2025 | |
| Ucb, INC. | $261.55 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $182.34 | 2020-2025 | Otezla, Otezla |
| Genzyme Corporation | $164.12 | 2019-2024 | |
| Pfizer INC. | $161.62 | 2019-2024 | |
| Kerecis Limited | $134.22 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Sun Pharmaceutical Industries INC. | $134.05 | 2021-2025 | Blu-U, Ilumya |
| Lilly USA, LLC | $90.70 | 2020-2023 | Olumiant, Taltz |
| E.R. Squibb & Sons, L.L.C. | $86.63 | 2022-2025 | Sotyktu |
| Incyte Corporation | $81.56 | 2022-2024 | Opzelura |
| Galderma Laboratories, L.P. | $72.34 | 2022-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.24 | 2022-2025 | Spevigo |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $57.02 | 2023 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $45.15 | 2023 | Puraply |
| Melinta Therapeutics, LLC | $44.54 | 2019 | |
| Leo Pharma INC. | $30.08 | 2019 | |
| Kyowa Kirin, INC. | $26.13 | 2023 | Poteligeo |
| Convatec INC. | $25.08 | 2025 | |
| Dermavant Sciences, INC. | $23.94 | 2023 | Vtama |
| Merck Sharp & Dohme LLC | $22.56 | 2023 | Keytruda |
| Strata Skin Sciences, INC. | $22.33 | 2025 | Xtrac |
| Mayne Pharma Commercial LLC | $16.96 | 2020 | |
| Boston Scientific Corporation | $16.92 | 2023 | Varithena Administration Pack |
| Celgene Corporation | $16.41 | 2019 | |
| Arcutis Biotherapeutics, INC. | $15.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jawitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.